Current Medicinal Chemistry

Editorial (Thematic Issue: Experimental Pharmacological Targets for the Treatment of Cardiac Arrhythmias: Beyond the Vaughn-Williams Classification)
pp. 1269-1270(2)
Authors: Eckardt, Lars; Pott, Christian

Late Sodium Current Inhibition: The Most Promising Antiarrhythmic Principle in the Near Future?
pp. 1271-1280(10)
Authors: Frommeyer, G.; Milberg, P.; Maier, L.S.; Eckardt, L.

The Role of Transcription Factors in the Formation of an Arrhythmogenic Substrate in Congestive Human Heart Failure
pp. 1281-1298(18)
Authors: Schulte, J.S.; Seidl, M.D.; Muller, F.U.

Experimental Antiarrhythmic Targets: CaMKII Inhibition – Ready for Clinical Evaluation?
pp. 1299-1307(9)
Author: S. Maier, Lars

Pharmacological Targeting in Inherited Arrhythmia Syndromes
pp. 1308-1319(12)
Authors: Zumhagen, S.; Strutz-Seebohm, N.; Seebohm, G.; Schulze-Bahr, E.

Functional Genomics in Zebrafish as a Tool to Identify Novel Antiarrhythmic Targets
pp. 1320-1329(10)
Authors: Pott, A.; Rottbauer, W.; Just, S.

Advantages and Limitations of Transgenic Mice: The Role of the Na+/Ca2+ Exchanger in Cardiac Electrophysiology and Arrhythmia
pp. 1330-1335(6)
Authors: Bogeholz, N.; Eckardt, L.; Pott, C.

Insight into the Medicinal Chemistry of EGFR and HER-2 Inhibitors
pp. 1336-1350(15)
Authors: Wang, C.; Gao, H.; Dong, J.; Wang, F.; Li, P.; Zhang, J.

Interlinking of Hypoxia and Estrogen in Thyroid Cancer Progression
pp. 1351-1360(10)
Authors: Rajoria, S.; Hanly, E.; Nicolini, A.; George, A.L.; Geliebter, J.; Shin, E.J.; Suriano, R.; Carpi, A.; Tiwari, R.K.

Developmental Regulated Expression of Anti- and Pro-Apoptotic BCL-2 Family Genes During Human Early Embryonic Development
pp. 1361-1369(9)
Authors: Boumela, I.; Assou, S.; Haouzi, D.; Déchaud, H.; Ait-Ahmed, O.; Hamamah, S.